EUVIMEDEUVIMED entdecken
Crossref

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?

Giovanni Martinelli, Simona Soverini, Ilaria Iacobucci, Cristina Papayannidis, Daniela Cilloni, Michele Baccarani

Hematology Reports · 2009

DOI: 10.4081/hr.2009.e1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology Reports, 2009. Verfasst von Giovanni Martinelli und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Martinelli, G., Soverini, S., Iacobucci, I., Papayannidis, C., Cilloni, D., & Baccarani, M. (2009). Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?. Hematology Reports. https://doi.org/10.4081/hr.2009.e1

Vancouver

Martinelli G, Soverini S, Iacobucci I, Papayannidis C, Cilloni D, Baccarani M. Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?. Hematology Reports. 2009. doi:10.4081/hr.2009.e1

BibTeX
@article{Martinelli2009,
  author = {Martinelli, Giovanni and Soverini, Simona and Iacobucci, Ilaria and Papayannidis, Cristina and Cilloni, Daniela and Baccarani, Michele},
  title = {Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?},
  journal = {Hematology Reports},
  year = {2009},
  doi = {10.4081/hr.2009.e1}
}
Kostenlos starten →